 |
Hepatitis B immune globulin intravenous (human) |
|---|---|
| Trade Name | Nabi-Hb |
| Orphan Indication | Prophylaxis against hepatitis B virus reinfection in liver transplant patients |
| USA Market Approval | USA |
| USA Designation Date | 1995-03-08 00:00:00 |
| Sponsor | Biotest Pharmaceuticals Corporation;5800 Park of Commerce Blvd., NW;Boca Raton, Florida, 33487 |
